| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448041 Colon cancer marker |
| 09/10/2002 | US6448040 Nucleic acid molecules encoding hypusine mutants having the biological activity, of inhibiting cellular proliferation |
| 09/10/2002 | US6448037 PgsA |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448034 Production of variant nisin |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448007 Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448005 14723 Receptor, a novel G-protein coupled receptor |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447784 Genetically engineered salmonella for use in the treatment of cancer |
| 09/10/2002 | US6447770 Biocontrol agents for take-all |
| 09/10/2002 | CA2242323C Fermentation control |
| 09/10/2002 | CA2234876C Positive selection vector for bacillus sp. |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/08/2002 | CA2363461A1 Methods for producing proteins by using cell-free protein synthesis systems |
| 09/06/2002 | WO2002068927A2 Using viruses to detect or purify proteins |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068676A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 09/06/2002 | WO2002068663A1 Tau-opathy model |
| 09/06/2002 | WO2002068662A1 Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method |
| 09/06/2002 | WO2002068661A1 FUSED PROTEIN HAVING β1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE II ACTIVITY AND PROCESS FOR PRODUCING THE SAME |
| 09/06/2002 | WO2002068660A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | WO2002068659A1 Agarase and gene thereof |
| 09/06/2002 | WO2002068658A1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase |
| 09/06/2002 | WO2002068655A1 Method of searching for remedy for hepatitis d |
| 09/06/2002 | WO2002068653A2 Tri-hybrid melanoma antigen |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068647A2 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | WO2002068645A2 Compositions and methods relating to breast specific genes and proteins |
| 09/06/2002 | WO2002068636A1 Methods and agents for modifying human angiogenesis |
| 09/06/2002 | WO2002068630A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068613A1 Biosynthesis of polyketide synthase substrates |
| 09/06/2002 | WO2002068612A1 Method for increasing the intracellular glutamate concentration in yeast |
| 09/06/2002 | WO2002068611A1 Method and system of disposing food wastes |
| 09/06/2002 | WO2002068607A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 09/06/2002 | WO2002068605A2 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | WO2002068600A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | WO2002068597A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068589A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068583A2 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068468A2 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 09/06/2002 | WO2002068467A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 09/06/2002 | WO2002068459A2 Non aggregating fluorescent proteins and methods for using the same |
| 09/06/2002 | WO2002068436A1 Avilamycin derivatives |
| 09/06/2002 | WO2002067986A2 Symbiotic regenerative agent |
| 09/06/2002 | WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002050262A3 Mutant mycobacteria for use in therapy |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002020842A8 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/06/2002 | WO2002012901A3 Use of grf1 protein for screening molecules |
| 09/06/2002 | WO2002011746A3 Chlorella preparations exhibiting immunomodulating properties |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2002000879A3 Methods for producing modified glycoproteins |
| 09/06/2002 | WO2002000687A3 Antimicrobial peptides and methods of use thereof |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001073093A3 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001062066A9 For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged culture |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031040A9 Host-vector systems in order to over-produce thermolabile enzymes originating from psychrophilic organisms |
| 09/06/2002 | WO2001030851A9 Idiotype vaccines |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001007627A9 Drosophila recombination-associated protein and methods for use |
| 09/06/2002 | WO2000073462A9 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2833423A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2439492A1 Tri-hybrid melanoma antigen |
| 09/06/2002 | CA2439472A1 Methods and compositions for modifying apolipoprotein b mrna editing |
| 09/06/2002 | CA2439400A1 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | CA2439383A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439185A1 Vector constructs |
| 09/06/2002 | CA2439155A1 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 09/06/2002 | CA2439150A1 Avilamycin derivatives |
| 09/06/2002 | CA2438923A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2438886A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | CA2438884A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2438798A1 Biosynthesis of polyketide synthase substrates |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 09/06/2002 | CA2438205A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437530A1 Symbiotic regenerative agent |
| 09/06/2002 | CA2437364A1 Proteins and nucleic acids encoding same |